Europe · General news · Swissinfo

Roche Drug Outshines Amgen, Bristol Rivals in Lung Cancer Study

Published by Swissinfo · Switzerland 9 h ago

A Roche Holding AG drug billed as a potential blockbuster helped patients with a form of lung cancer that had spread live almost six months longer than two competitive medicines.

Read the full article on Swissinfo Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.swissinfo.ch)

Also worth reading

Daily Mail

Storm Boelo causes devastation after man, 60, killed by falling tree and flooding batters Scotland - as 85mph winds leave tens of thousands left without power across Britain

Metro

Gary Neville lifts lid on the ‘nothing’ Man Utd players he’s ‘got no time for’

Daily Mirror

Woman 'jumps from balcony' to escape Gateshead flats fire as residents evacuated

The Independent

Meat-flavoured crisps could face rebrand under new EU rules

RTÉ

France's Le Pen vows to restore 'rule of law' if elected

Sky News